Skip to page content

Global Health

Featured

Nations throughout the world face ongoing challenges when it comes to health care quality, costs, delivery, and access; disease prevention; and public health preparedness. RAND analyzes these global health issues and offers recommendations to help governments, health organizations, and other stakeholders arrive at better outcomes.

Report
Public Health and Soft Power: The Republic of Korea's Initial COVID-19 Response and Its Implications
During the early days of the COVID-19 pandemic, the Republic of Korea (ROK) had one of the highest success rates in adopting effective nonpharmaceutical interventions. Can these pandemic response and foundation characteristics be turned into soft power assets for ROK?
Sep 7, 2022
Multimedia
Addressing Vaccine Hesitancy with Research
RAND senior physician policy researcher Courtney Gidengil reveals the biggest driver behind the hesitancy to receive the COVID-19 vaccine.
Jul 26, 2022

Explore Global Health

Commentary
Can South Korea Help the World Beat the Next Pandemic?
As the world emerges from the long and devastating COVID-19 pandemic, nations around the world, including the United States, could look to South Korea's near-perfect response as a model for dealing with future public health crises.
Sep 7, 2022
Journal Article
Implementation of South Africa's Central Chronic Medicine Dispensing and Distribution Program for HIV Treatment: A Qualitative Evaluation
Participants had highly favorable attitudes about the Chronic Care and Medicine Dispensing and Distribution (CCMDD) program for HIV treatment. Patient-level barriers to care included inadequate education about CCMDD and inability to get refills. Organizational-level barriers included challenges with communication and transportation, errors in medication packaging and tracking, rigid rules, and inadequate infrastructure.
Jun 23, 2022
Commentary
America Can Still Deliver on Global Vaccine Diplomacy
It is hard to see how science alone can end the pandemic without the rallying power of global diplomacy. The United States has played a leadership role in previous outbreaks, such as Ebola. It could play a similar role now to help consign the current pandemic to epidemic status.
Dec 28, 2021
Blog
U.S. 'Entanglement,' Global Health Cooperation, Community Stress: RAND Weekly Recap
This weekly recap focuses on competing claims about U.S. partnerships and allies, responding to Russia's tactics in Ukraine, helping communities recover from stress, and more.
Nov 26, 2021
Commentary
Global Health Data Sharing: The Case of China and the Two Coronavirus Pandemics
Tensions over the coronavirus seem to be prompting China to isolate itself in terms of data sharing. But the first coronavirus pandemic in 2003 actually helped open China to health collaborations with other countries. World leaders may be doing their citizens a disservice when they allow toxic geopolitics to undercut trust and international collaborations that took decades to build.
Nov 22, 2021
Report
Most U.S. Drug Shortages Appear to Be Domestic in Scope
Major U.S. drug shortages are rarely associated with volume and price changes in other countries. A global perspective is important when addressing shortages, but policymakers and the health care system should explore ways to leverage the supply of drugs in other countries in response to U.S. shortages.
Oct 27, 2021
Journal Article
What If Progress Meant Well-Being for All? U.S. Innovators Use Global Insights to Shift the Narrative and Surface Opportunities Ahead
In many countries, progress is sharply defined only as economic growth. What if that narrative shifted and progress were defined as well-being for all people?
Sep 1, 2021
Commentary
Split-Screen Pandemic Recovery Isn't Sustainable
In a world connected by commerce and the air we breathe, it's hard to see how any COVID-19 recovery that's confined to specific segments of the population is sustainable. Failing to address gaps in the pandemic response would run the risk that a future mutation of this virus could send us scurrying for cover. Again.
Jul 20, 2021
Blog
Vaccine Hesitancy, Working from Home, Arctic Diplomacy: RAND Weekly Recap
This weekly recap focuses on vaccine hesitancy as a symptom of ‘Truth Decay,’ how to make remote work beneficial for all, U.S. Arctic diplomacy, and more.
May 21, 2021
Commentary
Vaccine Patents Debate Risks Becoming a Sideshow
As COVID-19 cases continue to surge around the world, the debate is raging over whether patents on existing vaccines should be waived. But the global community could view patent waivers as just one of many available tools for speeding up vaccine delivery worldwide.
May 17, 2021
Commentary
America Could Do More to Get the World Vaccinated
After waging its own withering battle with COVID-19, the United States appears to be coming to grips with the pandemic and its economy is recovering. Now could be the time for America to play a greater role in global vaccination, both out of generosity and self-interest.
May 4, 2021
Blog
Biden's First Address to Congress: Insights from RAND
President Joe Biden addressed a joint session of Congress, summarizing his administration's early COVID-19 response and outlining plans that aim to loosen the pandemic's year-long grip on a weary nation. The speech reflected the fact that the United States faces policy challenges across a wide range of domains.
Apr 29, 2021
Report
Measures and Methodology for International Comparisons of Health Care System Performance: Final Report
RAND researchers worked with 15 experts in quality measurement, clinical care, and health economics to generate potential measure constructs that could improve the U.S. ability to learn from international comparisons of health system performance.
Feb 24, 2021
Commentary
Equal, Rapid Access to Vaccines Is More Important Than Ever as New COVID-19 Variants Emerge
Vaccine nationalism could prolong the pandemic and lead to preventable deaths. If some countries don't receive timely access to vaccines, then the virus will continue to spread in some populations, mutate further, and potentially render existing vaccines less effective.
Feb 9, 2021
Commentary
Vaccine Nationalism Has Real Economic Consequences
Vaccine nationalism, in which countries prioritize their domestic needs at the expense of others, will have significant global economic consequences. Major economies actually have more to gain by helping to make an effective COVID-19 vaccine widely available globally.
Dec 30, 2020
Journal Article
Reflections on the 7th International Jerusalem Conference on Health Policy in the Wake of the Covid-19 Outbreak
In 2019, a conference in Israel showcased new frontiers in technology in healthcare, highlighting research conducted in Israel as well as across the globe.
Dec 30, 2020
Research Brief
The economic benefits of equitable global access to COVID-19 vaccines
Researchers used a global macroeconomic model to examine the economic effects of vaccine nationalism. This brief highlights the cost to 30 high-income countries if low and middle-income countries miss out on initial access to COVID-19 vaccines.
Dec 17, 2020
Research Brief
Unequal Access to COVID-19 Vaccines Would Further Damage the Global Economy
As long as the coronavirus is not under control in all regions of the world there will continue to be a global economic cost associated with COVID-19. Vaccine nationalism could cost up to $1.2 trillion a year in GDP. If the poorest countries cannot access vaccines, the loss would be between $60 and $340 billion a year.
Nov 5, 2020

1
2
3
4
5
6
7
8
9
10
Next

RAND Topic:
Global Health

Topic Synonyms:
Global Health Environment

Research conducted by

Researcher Spotlight

Padmaja Vedula

Senior Information Scientist

Padmaja Vedula is a senior information scientist at the RAND Corporation, specializing in systems architecture, cybersecurity, cyber policy and deterrence, emerging technologies, and digital transformation. She has a multidisciplinary background and her other areas of interest include technology…
Zachary Wagner

Economist

Zachary Wagner is an economist at the RAND Corporation and a professor of policy analysis at the Pardee RAND Graduate School. He is a health economist with training in both applied microeconomics and public health. His research uses economic theory and econometrics to study how people make…

Explore Our People »